Hopkins RJ - Search Results

1

Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis.

Ionin B, Hopkins RJ, Pleune B, Sivko GS, Reid FM, Clement KH, Rudge TL Jr, Stark GV, Innes A, Sari S, Guina T, Howard C, Smith J, Swoboda ML, Vert-Wong E, Johnson V, Nabors GS, Skiadopoulos MH. Ionin B, et al. Among authors: hopkins rj. Clin Vaccine Immunol. 2013 Jul;20(7):1016-26. doi: 10.1128/CVI.00099-13. Epub 2013 May 8. Clin Vaccine Immunol. 2013. PMID: 23658392 Free PMC article. Clinical Trial.

2

Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.

Rynkiewicz D, Rathkopf M, Sim I, Waytes AT, Hopkins RJ, Giri L, DeMuria D, Ransom J, Quinn J, Nabors GS, Nielsen CJ. Rynkiewicz D, et al. Among authors: hopkins rj. Vaccine. 2011 Aug 26;29(37):6313-20. doi: 10.1016/j.vaccine.2011.05.047. Epub 2011 May 30. Vaccine. 2011. PMID: 21624418 Clinical Trial.

3

Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers.

Hopkins RJ, Daczkowski NF, Kaptur PE, Muse D, Sheldon E, LaForce C, Sari S, Rudge TL, Bernton E. Hopkins RJ, et al. Vaccine. 2013 Jun 26;31(30):3051-8. doi: 10.1016/j.vaccine.2013.04.063. Epub 2013 May 10. Vaccine. 2013. PMID: 23701746 Free PMC article. Clinical Trial.

4

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax.

Mytle N, Hopkins RJ, Malkevich NV, Basu S, Meister GT, Sanford DC, Comer JE, Van Zandt KE, Al-Ibrahim M, Kramer WG, Howard C, Daczkowski N, Chakrabarti AC, Ionin B, Nabors GS, Skiadopoulos MH. Mytle N, et al. Among authors: hopkins rj. Antimicrob Agents Chemother. 2013 Nov;57(11):5684-92. doi: 10.1128/AAC.00458-13. Epub 2013 Aug 26. Antimicrob Agents Chemother. 2013. PMID: 23979731 Free PMC article. Clinical Trial.

5

Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909).

Minang JT, Inglefield JR, Harris AM, Lathey JL, Alleva DG, Sweeney DL, Hopkins RJ, Lacy MJ, Bernton EW. Minang JT, et al. Among authors: hopkins rj. Vaccine. 2014 Nov 28;32(50):6847-54. doi: 10.1016/j.vaccine.2014.01.096. Epub 2014 Feb 13. Vaccine. 2014. PMID: 24530403 Free PMC article. Clinical Trial.

6

Phase 3 trial evaluating the immunogenicity and safety of a three-dose BioThrax® regimen for post-exposure prophylaxis in healthy adults.

Hopkins RJ, Howard C, Hunter-Stitt E, Kaptur PE, Pleune B, Muse D, Sheldon E, Davis M, Strout C, Vert-Wong K. Hopkins RJ, et al. Vaccine. 2014 Apr 17;32(19):2217-24. doi: 10.1016/j.vaccine.2014.01.073. Epub 2014 Mar 6. Vaccine. 2014. PMID: 24613523 Clinical Trial.

7

Efficacy and safety of AVP-21D9, an anthrax monoclonal antibody, in animal models and humans.

Malkevich NV, Hopkins RJ, Bernton E, Meister GT, Vela EM, Atiee G, Johnson V, Nabors GS, Aimes RT, Ionin B, Skiadopoulos MH. Malkevich NV, et al. Among authors: hopkins rj. Antimicrob Agents Chemother. 2014 Jul;58(7):3618-25. doi: 10.1128/AAC.02295-13. Epub 2014 Apr 14. Antimicrob Agents Chemother. 2014. PMID: 24733473 Free PMC article. Clinical Trial.

8

Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults.

Hopkins RJ, Kalsi G, Montalvo-Lugo VM, Sharma M, Wu Y, Muse DD, Sheldon EA, Hampel FC, Lemiale L. Hopkins RJ, et al. Vaccine. 2016 Apr 19;34(18):2096-105. doi: 10.1016/j.vaccine.2016.03.006. Epub 2016 Mar 12. Vaccine. 2016. PMID: 26979136 Free PMC article. Clinical Trial.

9

Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule.

Longstreth J, Skiadopoulos MH, Hopkins RJ. Longstreth J, et al. Among authors: hopkins rj. Expert Rev Vaccines. 2016 Dec;15(12):1467-1479. doi: 10.1080/14760584.2016.1254556. Expert Rev Vaccines. 2016. PMID: 27792416 Review.

10

Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older.

Wolfe DN, Espeland EM, Gao Y, Lu D, Blatner G, Amass K, Horwith G, Tong XM, Hopkins R, David GL, Jepson BM, King JC Jr. Wolfe DN, et al. Vaccine. 2020 Nov 25;38(50):7970-7976. doi: 10.1016/j.vaccine.2020.10.053. Epub 2020 Oct 28. Vaccine. 2020. PMID: 33129609 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page